CD34+ Cell Therapy for No-Option Refractory Disabling Angina: Time for FDA Approval? [electronic resource]
Producer: 20200414Description: 177-178 p. digitalISSN:- 1878-0938
No physical items for this record
Publication Type: Editorial; Comment
There are no comments on this title.
Log in to your account to post a comment.